Rim Diab: Presenting Protein S Research as a Rebalancing Strategy at ISTH 2026
Rim Diab, Scientist-Postdoc Researcher, Research Assistant, shared a post on LinkedIn:
“Grateful for the opportunity to share our latest research at the International Society on Thrombosis and Haemostasis (ISTH) 2026.
I had the privilege of presenting our work on Protein S as a hemostatic rebalancing strategy in both Factor XI deficiency and von Willebrand disease. It was a valuable experience to discuss these projects with researchers and clinicians from around the world.
A heartfelt thank you to my supervisors, Anne Angelillo-Scherrer and Raja Prince, for their guidance, support, and encouragement throughout these projects. I am also grateful to all my colleagues and collaborators whose contributions made this work possible.
I feel very fortunate to be part of BLEEDnFIRE Therapeutics to contribute to the development of new therapeutic approaches for bleeding disorders.”
Stay updated with Hemostasis Today.
-
Jul 18, 2026, 21:05Federica Fedele: From One-Size-Fits-All to Personalized Care
-
Jul 18, 2026, 21:04Sandra RodrÃguez Coma: A Great Experience With the Werfen Team at ISTH 2026
-
Jul 18, 2026, 20:58Heghine Khachatryan: Cancer-Associated ATE – An Underrecognized Challenge in Modern Oncology
-
Jul 18, 2026, 20:57Barbara Adams Krolak: The Science Was Even Hotter Than Paris
-
Jul 18, 2026, 20:15Ahmed Kotb: Exploring Qualitative Platelet Defects
-
Jul 18, 2026, 20:08Bianca Heidersdorf: Shaping the Future of Bleeding Disorders Support at ISTH 2026
-
Jul 18, 2026, 18:00Karen Schreiber: Advancing Thrombosis Epidemiology Through Global Collaboration at ISTH 2026
-
Jul 18, 2026, 17:34Living With ITP – A New Resource for Navigating Your Diagnosis – ITP Support Association
-
Jul 18, 2026, 17:34Mona Alfaraj: It Was a Hot Week Attending ISTH 2026 Congress in Paris